Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SAN-903 reduces lung inflammation and fibrosis in mouse model of IPF

May 4, 2021

Mesoblast reports 60-day results on remestemcel-L in COVID-19 related ARDS

April 30, 2021

New IRAK-4 inhibitors identified at Bayer

April 28, 2021

CL-2020 studied for ARDS related to COVID-19 in Japan

April 21, 2021

Phase II study application for FB-704A in severe asthma receives approval in Taiwan

April 21, 2021

Krystal Biotech provides development updates for KB-407 and KB-408

April 21, 2021

Nanjing TransThera Biosciences patents PADI4 inhibitors

April 19, 2021

scRNA-seq and gene expression analysis of lung immune cells in a model of RA-associated lung disease

April 13, 2021

EpiEndo begins first-in-human trial of EP-395 for chronic airway diseases

April 13, 2021

Boehringer Ingelheim starts enrolling participants in phase I study of BI-1323495

April 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...